A meta-regression study suggested a linear relationship between HbA1c reduction and MACE risk in patient with arGLP-1.89 Publication on mediation analyses also suggest that cardiovascular benefit could be mediated in part by effects on HbA1c, on blood pressure or reduction in urine albumin-creatinine ratio90,91 (see below), as well as by their effect on lipid profile.81 However, in subgroup analyses of cardiovascular safety studies, baseline HbA1c, weight, previous cardiovascular disease, or renal function did not predict the beneficial effects of these drugs on MACE,87 so other mechanisms, such as the previously mentioned anti-inflammatory, antifibrotic, antiatherogenic, vasodilator, or endothelial function-enhancing effects, have been suggested to influence the cardiovascular benefit of these drugs29,78 (Fig
Treatment Options Managing Hair Loss From GLP-1 Medications The good news: GLP-1-associated telogen effluvium is usually temporary, and there is a well-established toolkit of medical and regenerative options to support regrowth while you continue your weight-loss journey
Theranostics 11 , 22472262 (2021)
Evidence also supports a beneficial effect of exenatide on ectopic fat depots, with potential mechanisms that may not be entirely weight dependent
Novo Nordisk, the manufacturer of Ozempic, has stated that no reports of suicidal thoughts were found during its clinical trials
But what exactly is GLP-1, and how does it wield such significant influence over our appetite and health
